Warfighter Medical Research Program Under Award No News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update

Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAshleyr robinsonSath shuklaDepartment of healthWarfighter medical research program under award noNational institute of allergyDepartment of the armyBiomedical advanced researchDepartment of defenseLifesci advisorsSpero therapeutics incAdministration for strategic preparednessOffice of theHuman servicesDrug administration

Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections

Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesTed jenkinsKamal hamedLora grassilliDepartment of healthNational institute of allergyNational institutes of healthCenters for diseaseZeno groupWarfighter medical research program under award noDepartment of defenseDrug administrationOffice of theWorld health organizationHealth affairs

Spero Therapeutics (SPRO) Provides Corporate Update and 2024 Outlook

Spero Therapeutics (SPRO) Provides Corporate Update and 2024 Outlook
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSath shuklaBiomedical advanced researchTebipenem hbr researchSpero therapeutics incDevelopment authorityWarfighter medical research program under award noNational institute of allergyOffice of theHealth affairsAdministration for strategic preparednessGovernment agency researchDepartment of defenseUs department of healthDepartment of health

Spero Therapeutics Provides Corporate Update and 2024

In 2H 2024, expect to provide Phase 2a topline proof-of-concept data from our wholly-owned lead program SPR720 in NTM-PD patients Initiated dosing in.

United kingdomUnited statesLora grassilliTed jenkinsSath shuklaNational institutes of healthExchange commissionBiomedical advanced researchTebipenem hbr researchWarfighter medical research program under award noGovernment agency researchDevelopment authorityHuman servicesDepartment of defenseOffice of theAdministration for strategic preparedness

Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update – IT Business Net

Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomTed jenkinsSatyavrat sath shuklaJonb brussKevin winthropAnkit mahadeviaSath shuklaLora grassilliEsther rajaveluDepartment of healthGovernment agency researchZeno groupExchange commissionNational institutes of healthHuman services